155 related articles for article (PubMed ID: 25002176)
1. Is the heat on HEAT-PPCI appropriate?
Berger PB; Blankenship JC
Lancet; 2014 Nov; 384(9957):1824-1826. PubMed ID: 25002176
[No Abstract] [Full Text] [Related]
2. HEAT-PPCI sheds light on consent in pragmatic trials.
Shaw D
Lancet; 2014 Nov; 384(9957):1826-1827. PubMed ID: 25002175
[No Abstract] [Full Text] [Related]
3. Bivalirudin versus heparin use for patients undergoing PPCI.
Shah R
Lancet; 2015 May; 385(9982):2045. PubMed ID: 26009227
[No Abstract] [Full Text] [Related]
4. Bivalirudin versus heparin use for patients undergoing PPCI.
Miyasaka M; Wada Y; Kami M
Lancet; 2015 May; 385(9982):2044-5. PubMed ID: 26009225
[No Abstract] [Full Text] [Related]
5. Bivalirudin versus heparin use for patients undergoing PPCI.
Schneider DJ
Lancet; 2015 May; 385(9982):2044. PubMed ID: 26009224
[No Abstract] [Full Text] [Related]
6. Bivalirudin versus heparin use for patients undergoing PPCI.
Steg PG; van't Hof AW; Zeymer U; Goldstein P
Lancet; 2015 May; 385(9982):2043-4. PubMed ID: 26009223
[No Abstract] [Full Text] [Related]
7. Bivalirudin versus heparin use for patients undergoing PPCI - Authors' reply.
Shahzad A; Stables RH
Lancet; 2015 May; 385(9982):2045-6. PubMed ID: 26009226
[No Abstract] [Full Text] [Related]
8. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.
Shahzad A; Kemp I; Mars C; Wilson K; Roome C; Cooper R; Andron M; Appleby C; Fisher M; Khand A; Kunadian B; Mills JD; Morris JL; Morrison WL; Munir S; Palmer ND; Perry RA; Ramsdale DR; Velavan P; Stables RH;
Lancet; 2014 Nov; 384(9957):1849-1858. PubMed ID: 25002178
[TBL] [Abstract][Full Text] [Related]
9. Which antithrombotic to use during PCI?
Jolly SS; Yusuf S
Eur Heart J; 2010 Mar; 31(5):522-4. PubMed ID: 20150323
[No Abstract] [Full Text] [Related]
10. Bivalirudin: role in current percutaneous coronary intervention practice.
West N
Br J Hosp Med (Lond); 2005 Dec; 66(12):687-9. PubMed ID: 16417115
[No Abstract] [Full Text] [Related]
11. Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.
Lombo B; Díez JG
Future Cardiol; 2011 May; 7(3):281-5. PubMed ID: 21627469
[No Abstract] [Full Text] [Related]
12. Use of bivalirudin instead of heparin during a percutaneous coronary intervention in a patient with severe thrombocytopenia.
Bejarano J; Muniz AJ
J Invasive Cardiol; 2004 Sep; 16(9):535-6. PubMed ID: 15353815
[No Abstract] [Full Text] [Related]
13. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
[No Abstract] [Full Text] [Related]
14. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
French MH; Faxon DP
Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin in acute coronary syndromes and percutaneous coronary intervention.
Lee MS; Makkar RR
Rev Cardiovasc Med; 2006; 7 Suppl 3():S27-34. PubMed ID: 17224881
[TBL] [Abstract][Full Text] [Related]
16. Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.
Busch G; Steppich B; Sibbing D; Braun SL; Stein A; Groha P; Schömig A; Kastrati A; von Beckerath N; Ott I
Thromb Haemost; 2009 Feb; 101(2):340-4. PubMed ID: 19190819
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin for mechanical rotational atherectomy: the quest for better outcomes.
Shenoy C; Harjai KJ
J Interv Cardiol; 2010 Jun; 23(3):230-2. PubMed ID: 20636843
[No Abstract] [Full Text] [Related]
18. HORIZONS-AMI.
Webster MW
Lancet; 2010 Jan; 375(9712):375. PubMed ID: 20113821
[No Abstract] [Full Text] [Related]
19. Antithrombotics for PCI: an indigenous direct thrombin inhibitor (DTI) makes the cut.
Mukherjee D
Indian Heart J; 2008; 60(4):284-6. PubMed ID: 19242003
[No Abstract] [Full Text] [Related]
20. Overcoming heparin limitations in high-risk percutaneous coronary intervention: the alternative strategy-- replacing heparin with bivalirudin.
Henry TD
J Invasive Cardiol; 2002 Apr; 14 Suppl B():19B-29B. PubMed ID: 11967387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
